Story
Partners Group Explores €1.5 Billion Sale of Modular Builder Parmaco, Bloomberg Reports
Summary
The Swiss private equity firm is reportedly working with Bank of America to weigh options for the Finnish company, which could be valued at approximately €1.5 billion in a potential 2027 deal.
Partners Group Holding AG is exploring a potential sale of Parmaco Oy, a Finnish manufacturer of modular buildings, in a deal that could value the company at approximately €1.5 billion ($1.7 billion). The Swiss-based private equity firm has enlisted Bank of America Corp. to advise on its options, according to a Bloomberg report citing people familiar with the matter.
Following the news, shares of Partners Group (SIX:PGHN) traded 1.8% higher in Europe.
Potential Divestment Details
Deliberations are in a preliminary phase, and Partners Group may ultimately decide to retain the asset, the report noted. Should the firm proceed with a sale, a transaction would most likely occur in 2027.
Partners Group acquired Parmaco in 2021 from a consortium of investors led by Terra Firma Capital Partners for an undisclosed amount. The potential exit highlights ongoing private equity demand for infrastructure-adjacent assets that benefit from stable, long-term revenue streams tied to public sector clients.
AdAbout Parmaco
Parmaco specializes in designing, constructing, and leasing high-quality modular buildings. Its primary clients are municipalities, and its structures are often used as:
- Schools
- Day care centers
- Healthcare facilities
- Residential units
Headquartered in Finland, the company has expanded its operations into Sweden, Denmark, and Germany under Partners Group's ownership. Parmaco generates an annual turnover of around €100 million and employs approximately 300 people.
Read next
More on Stocks
FDA Launches Nationwide Search for Advisory Panel Experts
The U.S. Food and Drug Administration has initiated a nationwide recruitment drive to fill vacancies on its influential advisory committees, which provide non-binding recommendations on the approval of new drugs, vaccines, and medical devices.
Ford Stock Falls After CEO Confirms F-150 Production Halt Hit Q3 Volumes
Shares of the automaker declined after CEO Jim Farley acknowledged that a supplier-related shutdown of its most profitable truck line has negatively impacted third-quarter wholesale shipments.
ElevenLabs Valuation Doubles to $22 Billion in $300 Million Tender Offer
AI voice startup ElevenLabs has doubled its valuation to $22 billion following a $300 million employee tender offer, signaling strong investor confidence amid surging demand for its automated voice agent technology.
US Senate Blocks Bill to Restrict Congressional Stock Trading
Legislation designed to impose new limits on stock trading by members of the U.S. Congress has been blocked in the Senate after failing to secure enough votes to advance, according to reports.